Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overviewAll 13F holders of ADAPYFull Q2 2026 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q2 2021
Holdings of ADAPY by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−15,150−100.0%Sold outHolders
Q1 202215,150$31.0K<0.1%+1,150+8.2%AddedHolders
Q4 202114,000$53.0K<0.1%00.0%UnchangedHolders
Q3 202114,000$72.0K<0.1%−1,000−6.7%ReducedHolders
Q2 202115,000$64.0K<0.1%+15,000NewHolders